Tesamorelin
GHRH-analog research peptide · 10mg
99%+ Pure$75
Product Description
Tesamorelin is a synthetic Growth Hormone Releasing Hormone (GHRH) analogue with a hexapeptide extension at the N-terminus. This modification was designed to increase half-life and bioavailability compared to native GHRH. As a GHRH-analogue, Tesamorelin activates the GH axis and has been extensively researched for its effects on growth hormone dynamics and metabolic function.
Expert Insight
“Tesamorelin's hexapeptide extension represents a thoughtful modification of GHRH pharmacology, balancing potency with extended half-life. This makes it particularly valuable for research protocols investigating sustained GH-axis activation and chronic adaptation mechanisms.”
Research Pairing Suggestions
Both stimulate GH secretion but through different mechanisms and kinetics—Tesamorelin's extended GHRH signaling complements Ipamorelin's ghrelin receptor activation for optimized GH secretion research.
Research Highlights
GHRH analogue with hexapeptide N-terminal extension
Extended half-life compared to native GHRH
Peer-reviewed research on GH-axis dynamics
This calculator is a math tool only. It does not provide medical advice. Vital Peptides Labs sells research peptides for laboratory and research use only. Users are strongly encouraged to read the linked research, consult qualified professionals, and draw their own conclusions before making any decisions.
Reconstitution Calculator— Tesamorelin
Research Literature — Tesamorelin
The following is a summary of published research literature. This information is provided for educational reference only and does not constitute medical advice or research amount guidance.
Research Amounts in Literature
In published clinical trials, researchers administered Tesamorelin at a standard dose of 2 mg per day via subcutaneous administration. This is the dose used across major Phase 3 trials.
Frequency Protocols in Research
Published literature on Tesamorelin reports once-daily subcutaneous administration protocols, typically administered in the morning, over 26–52 week treatment periods.
Reconstitution Concentrations in Research
Published literature reports reconstitution of 10 mg vials in 3–5 mL bacteriostatic water, yielding concentrations of 2–3.3 mg/mL. Using 5 mL (2 mg/mL) is standard for daily-dose protocols where comfortable research volume matters.
Typical Syringe Ranges in Research
At 2 mg/mL (5 mL water), a standard 2 mg research dose equals 100 units (1.0 mL). At 3.3 mg/mL (3 mL water), the same dose equals 60 units (0.6 mL).
Tesamorelin
Add to your order
Pairs Well With
You'll Also Need
3mL / 23G Reconstitution Syringe
For mixing bacteriostatic water into lyophilized peptide vials
~$10–15
Buy on Amazon31G Research Syringe
For precise subcutaneous administration in research protocols
~$12–18
Buy on AmazonAlcohol Prep Pads
For sterilizing vial stoppers and work surfaces
~$5–8
Buy on AmazonBacteriostatic Water (10mL)
Sterile water with 0.9% benzyl alcohol for reconstitution
$10
ViewThis product is intended strictly for laboratory research and development purposes only. Not for human consumption, medical, veterinary, or household use. By purchasing this product, you confirm that you are at least 21 years of age and that the product will be used solely for legitimate research purposes.